Position in ZTS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$225,456,582
-$8,074,247 QoQ
Shares Held
3,137,442
+58.8% QoQ
Ownership
0.759%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#27
of 1,408 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $921,160,135 across 28 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
3,137,442 | $225,456,582 | |
| 2 | VTRS |
Viatris Inc
|
8,371,218 | $132,934,941 | |
| 3 | HLN |
Haleon plc
|
14,181,817 | $132,316,352 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,642,086 | $67,374,788 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
957,514 | $61,233,020 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,732,924 | $59,838,771 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
562,016 | $46,523,684 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,872,157 | $46,073,783 |
All Filings in ZTS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $225,456,582 | 3,137,442 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $233,530,829 | 1,975,559 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $382,296,143 | 3,038,437 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $394,746,046 | 2,697,827 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $229,362,214 | 1,470,742 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $106,760,377 | 648,408 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $43,612,939 | 267,679 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,819,288 | 19,548 | Shares | Defined | 2024-11-14 | |
| 2023-06-30 | $26,261,680 | 152,498 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $29,677,250 | 178,306 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $103,533,031 | 706,469 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $150,041,898 | 1,011,814 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $358,699,192 | 2,086,795 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $627,334,828 | 3,326,448 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $298,727,372 | 1,224,142 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $274,918,547 | 1,416,084 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $170,952,873 | 917,326 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $182,888,610 | 1,161,345 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $31,845,344 | 192,419 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $782,034 | 4,729 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $11,215,764 | 81,843 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $39,194,183 | 333,029 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||